Mark Zaleski, Associated Press file
Mylan, currently in the cross-hairs over severe price hikes for its EpiPen, said Thursday that it will expand programs that lower out-of-pocket costs by as much as half. 
Getting your player ready...
Colorado residents who don’t have a state-regulated plan and aren't covered by Medicare or Medicaid will be able to get epinephrine auto-injectors for $60 if they apply for a new affordability program next year.
Already have an account Log In
This article is only available to subscribers
Trusted Local News
Standard Digital
$1 for 1 year
Offer valid for non-subscribers only
